US FDA’s Science Strategies Program Aims To Proactively Tackle Drug Development Hurdles

 
• By Sue Sutter
  
Chess game
The FDA Office of New Drugs’ Science Strategies program aims to take on some of the most challenging drug development hurdles. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D